Development and application of real-time PCR assay for quantification of Mycobacterium ulcerans DNA

被引:51
作者
Rondini, S
Mensah-Quainoo, E
Troll, H
Bodmer, T
Pluschke, G
机构
[1] Swiss Trop Inst, CH-4002 Basel, Switzerland
[2] Solvias AG, Basel, Switzerland
[3] Inst Infect Dis, Bern, Switzerland
[4] Ghana Hlth Serv, Amasaman, Ga District, Ghana
关键词
D O I
10.1128/JCM.41.9.4231-4237.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Buruli ulcer, an infection caused by Mycobacterium ulcerans, is, after tuberculosis and leprosy, the third most common mycobacterial disease. The mode of transmission of M. ulcerans is not exactly known, but since Buruli ulcer often occurs in focalized swampy areas, it is assumed that there is a reservoir of the pathogen in stagnant water. Buruli ulcer usually starts as a painless nodule and can lead to massive destruction of skin, subcutaneous tissue, and eventually muscle and bone. Currently the only recommended treatment is wide surgical excision. In this report we describe the development of a real-time PCR method for the quantification of M. ulcerans DNA (IS2404 TaqMan). The highly specific assay is based on the detection of the M. ulcerans specific insertion sequence IS2404. The IS2404 TaqMan assay turned out to be about 10 times more sensitive than the available conventional PCR-based diagnostic test. It is demonstrated that the IS2404 TaqMan assay is suitable for the quantitative assessment of the dissemination of the mycobacteria in Buruli ulcer lesions. Prototype results obtained with excised tissue from a patient with a late preulcerative Buruli ulcer lesion reconfirmed earlier histopathological findings indicating that tissue damage occurs far beyond the regions in which large numbers of mycobacteria are detectable. The IS2404 TaqMan assay should be a useful tool for both diagnosis and research into the pathology and mode of transmission of this still inadequately investigated mycobacterial disease.
引用
收藏
页码:4231 / 4237
页数:7
相关论文
共 30 条
[1]  
Asiedu K., 2000, Buruli ulcer: Mycobacterium ulcerans infection
[2]   Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatment [J].
Bockenstedt, LK ;
Mao, JL ;
Hodzic, E ;
Barthold, SW ;
Fish, D .
JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (10) :1430-1437
[3]   Characterization of an unusual mycobacterium:: a possible missing link between Mycobacterium marinum and Mycobacterium ulcerans [J].
Chemlal, K ;
Huys, G ;
Laval, F ;
Vincent, V ;
Savage, C ;
Gutierrez, C ;
Laneelle, MA ;
Swings, J ;
Meyers, WM ;
Daffe, M ;
Portaels, F .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (07) :2370-2380
[4]  
Connor DH, 1976, PATHOLOGY TROPICAL E, P226
[5]   Mycobacterium ulcerans disease (Buruli ulcer) following human bite [J].
Debacker, M ;
Zinsou, C ;
Aguiar, J ;
Meyers, W ;
Portaels, F .
LANCET, 2002, 360 (9348) :1830-1830
[6]   Bactericidal activity of rifampin-amikacin against Mycobacterium ulcerans in mice [J].
Dega, H ;
Bentoucha, A ;
Robert, J ;
Jarlier, V ;
Grosset, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (10) :3193-3196
[7]   Measurement of sputum Mycobacterium tuberculosis messenger RNA as a surrogate for response to chemotherapy [J].
Desjardin, LE ;
Perkins, MD ;
Wolski, K ;
Haun, S ;
Teixeira, L ;
Chen, Y ;
Johnson, JL ;
Ellner, JJ ;
Dietze, R ;
Bates, J ;
Cave, MD ;
Eisenach, KD .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (01) :203-210
[8]   Comparison of the ABI 7700 system (TaqMan) and competitive PCR for quantification of IS6110 DNA in sputum during treatment of tuberculosis [J].
Desjardin, LE ;
Chen, Y ;
Perkins, MD ;
Teixeira, L ;
Cave, MD ;
Eisenach, KD .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (07) :1964-1968
[9]   Mycobacterium ulcerans cytotoxicity in an adipose cell model [J].
Dobos, KM ;
Small, PL ;
Deslauriers, M ;
Quinn, FD ;
King, H .
INFECTION AND IMMUNITY, 2001, 69 (11) :7182-7186
[10]  
Espey David K., 2002, International Journal of Infectious Diseases, V6, P60, DOI 10.1016/S1201-9712(02)90138-4